Characterization of a quaternary liquid system improving the bioavailability of poorly water soluble drugs

Journal of Colloid and Interface Science

Volumn 263, Issue 2, 2003, Pages 590-596

  Meriani, F ^a   Coceani, N ^b   Sirotti, C ^b   Voinovich, D ^a   Grassi, M ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Eurand SpA   (Italy)

Author keywords

Ethanol; Interfacial properties; Modeling; Phase diagram; Triacetin; Tween 80

Indexed keywords

COMPOSITION; DRUG PRODUCTS; GIBBS FREE ENERGY; INTERFACES (MATERIALS); MATHEMATICAL MODELS; SOLUBILITY; SURFACE ACTIVE AGENTS; WATER;

BIOAVAILABILITY;

MIXTURES;

ALCOHOL; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSORBATE 80; SURFACTANT; TRIACETIN; WATER OIL CREAM;

ARTICLE; BIOAVAILABILITY; CALCULATION; CHEMICAL COMPOSITION; DRUG INDUSTRY; DRUG SOLUBILITY; LIQUID; MATHEMATICAL MODEL; MISCIBILITY; PRIORITY JOURNAL; QUATERNARY; THEORY;

EID: 0038385098     PISSN: 00219797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9797(03)00321-7     Document Type: Article

References (22)

1. van de Waterbeemd H. Dressman J.B., Lennernäs H. Oral Drug Absorption, Prediction and Assessment. 2000;Dekker, New York/Basel. Chap. 4.
2. Yu L.X., Gatlin L., Amidon G.L. Amidon G.L., Lee P.I., Topp E.M. Transport Processes in Pharmaceutical Systems. 2000;Dekker, New York/Basel. Chap. 10.
3. Grassi M., Coceani N., Magarotto L. Int. J. Pharm. Sci. 239:2002;157.
4. Pharmacos 4, Eudralex Collection, Medicinal Products for Human Use: Guidelines, Vol. 3C, p. 234 (internet site: http://pharmacos.eudra.org/F2/eudralex/vol-3/home.htm ).
5. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. Pharm. Res. 12:1995;413.
6. Charman S.A., Charman W.N., Rogge M.C., Wilson T.D., Dutko F.J., Pouton C.W. Pharm. Res. 9:1992;87.
7. Kumar P., Mittal L.K. Handbook of Microemulsion Science and Technology. 1999;Dekker, New York. p. 755.
8. Constantinides P.P. Pharm. Res. 12:1995;1561.
9. Gasco M.R. Solans C., Kunieda H. Industrial applications of microemulsions. 1997;Dekker, New York/Basel/Hong Kong. Chap. 5.
10. Pouton C.W. Adv. Drug Del. Rev. 25:1997;47.
11. Frömming K.H., Szejtli J. Cyclodextrins in Pharmacy. 1994;Kluwer Academic, Boston/London.
12. Santacesaria E., Visca M. Chimica Fisica dei Colloidi e Delle Interfasi. 1985;Clup, Milano.
13. Grassi M., Colombo I., Lapasin R. J. Contr. Rel. 68:(1):2000;97.
14. Dobetti L., Cadelli G., Furlani D., Zotti M., Ceschia D., Grassi M. Proc. 28th Int. Symp. on Contr. Rel. of Biact. Mat., San Diego. 2001;. No. 6059.
15. F. Meriani, Eurand Trieste, Internal report R005, 2000.
16. Hutt V., Waitzinger J., Macchi F. Clin. Drug. Invest. 21:(5):2001;361.
17. Naveen J.K., Kulkarni S.K. Indian Drugs. 38:(2):2001;63.
18. Sirotti C., Coceani N., Colombo I., Lapasin R., Grassi M. J. Membr. Sci. 204:2002;401.
19. Adamson A.W., Gast A.P. Physical Chemistry of Surfaces. 1997;Wiley, New York. p. 48.
20. COULTER® N4 Plus Submicron Particle Sizer Reference Manual. 1995;Coulter Corporation, Miami, FL. pp. 3-14.
21. Kumar P., Mittal K.L. Handbook of Microemulsion Science and Technology. 1999;228-232 Dekker, New York/Basel.
22. Tassios D.P. Applied Chemical Engineering Thermodynamics. 1993;Springer-Verlag, Berlin/New York. p. 466.